During the past decade, Kaiser Permanente Health Care - Portland conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 18 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Health Care - Portland" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 9 trials, followed by "NSABP Foundation Inc" with 6 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Health Care - Portland" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Health Care - Portland" are "Breast Cancer" (10 trials), "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials), "Prostate Cancer" (3 trials) and "Chemotherapeutic Agent Toxicity" (2 trials). Many other conditions were trialed in "Kaiser Permanente Health Care - Portland" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Health Care - Portland" are "Drug" (21 trials), "Other" (8 trials), "Radiation" (5 trials), "Biological" (4 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (6 trials), "bevacizumab" (3 trials), "cisplatin" (3 trials), "cyclophosphamide" (3 trials) and "docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Health Care - Portland" are 12 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Health Care - Portland". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Kaiser Permanente Health Care - Portland, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Health Care - Portland, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Kaiser Permanente Health Care - Portland has several departments that took part in Clinical trials: "Kaiser Permanente Northwest Oncology Hematology" - 7 trials